Skip to main content
CROX
NASDAQ Manufacturing

Crocs Posts Record Q2 Revenue of $1.18B, Lifts Full-Year Outlook, and Supercharges Buyback to $2B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Positive
Importance info
8
Price
$119.7
Mkt Cap
$5.948B
52W Low
$73.205
52W High
$140.42
52W Position info
64% above low
Off High info
15% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

CROX sits 64% above its 52-week low of $73.205.

Summary

Crocs posted record Q2 revenue of $1.18B, raised full-year guidance, and expanded its buyback program to $2B — a powerful signal of financial strength after last year's impairment-driven loss.


Key Events · Earnings and Guidance · CROX

  • Record Q2 Revenue

    Revenue reached $1.18 billion, a 2.6% increase year-over-year, driven by Crocs Brand growth of 4.3%.

  • Raised Full-Year Guidance

    Management lifted its full-year revenue and earnings outlook following the strong Q2 performance.

  • $1.5B Buyback Expansion

    The board approved a $1.5 billion increase to the share repurchase authorization, bringing the total available to approximately $2.0 billion.

  • No HEYDUDE Impairment Repeat

    Unlike Q2 2025, which included $738.1 million in HEYDUDE impairment charges, this quarter had no such write-downs, allowing net income of $204.9 million.


Analysis · CROX · Manufacturing

A record second quarter underscores Crocs' momentum: revenue climbed 2.6% year-over-year to $1.18 billion, and management responded by raising its full-year guidance. The contrast with last year's $738 million impairment-driven loss is stark. Adding to the bullish signal, the board authorized a $1.5 billion increase to the share repurchase program, bringing total capacity to roughly $2 billion. That level of buyback firepower, paired with a quarter free of the HEYDUDE impairment charges that sank prior results, reflects deep confidence in the brand turnaround and cash generation. Although the stock slipped 11% premarket on flat Q3 revenue guidance, the dominant story remains the underlying Q2 beat and the aggressive capital return plan.

At the time of this filing, CROX was trading at $119.70 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $73.21 to $140.42. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CROX - Latest Insights

CROX
Jul 30, 2026, 7:28 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
CROX
Jul 30, 2026, 7:11 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
CROX
Jul 30, 2026, 7:02 AM EDT
Filing Type: 8-K
Importance Score:
8
CROX
Jun 10, 2026, 12:51 PM EDT
Filing Type: 8-K
Importance Score:
8
CROX
Jun 05, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7